BioSpace News Archive

Balance, equilibrium and stability in a risky environment concepts. Spheres balancing on a seesaw. Abstract 3D render.

ALS

BrainStorm levels up, bringing on former FDA leader Peter Pitts for new ALS bid

For Peter Pitts, a former associate commissioner at the FDA, the appointment to the board of BrainStorm Cell Therapeutics is an opportunity to fulfill a promise he made long ago to a patient with ALS.

June 2, 2026

·

5 min read

·

Heather McKenzie

Two man climbing on a rock. Work smart not hard concept. This is a 3d render illustration.

Insights

France’s biotech ambition is strong but its scale-up engine still needs work

Government backing, deep scientific talent and a robust pharma heritage are helping France punch above its weight, but turning research into investable companies remains a challenge.

June 2, 2026

·

3 min read

·

Jennifer C. Smith-Parker

China

Big Pharma makes ‘creative effort’ to fold Chinese assets into pipelines

Recent deals from Pfizer and Bristol Myers Squibb hint at Big Pharma’s more collaborative approach to partnering with Chinese companies.

June 2, 2026

·

2 min read

·

Tristan Manalac

China

Lilly bets $3B+ to add China’s Haisco to growing list of partners in five-program pact

Eli Lilly and the Haisco Pharmaceutical Group have yet to disclose what specific indications they plan to prioritize.

June 2, 2026

·

1 min read

·

Tristan Manalac

Hand putting print screen dart and target board wooden cube on up arrows. Target of investment and business concept.

mRNA

ASCO: Moderna’s mRNA-based melanoma vaccine shows ‘encouraging’ 5-year survival

When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in a mid-stage trial of advanced melanoma—a result analysts said could help “instill confidence” in the regimen.

June 2, 2026

·

2 min read

·

Tristan Manalac

Team up and teaming together to fight a big power as a group concept joining and united as a strong partnership with a common goal in a teamwork effort pulling diverse ropes against a large power in a 3D illustration style.

Antibody-drug conjugate (ADC)

ASCO: Merck overshadowed by upstart biotechs but TROP2 plans begin to pay off

Merck may not have had the splashiest presentation at the American Society of Clinical Oncology meeting, but the data show why the Big Pharma remains king of oncology, analysts say.

June 2, 2026

·

4 min read

·

Annalee Armstrong

New Year Direction Concept 2026 to 2033 and Sustainable Development Concept, Business Restart, Future Work 2026 to 2033 on Asphalt Road, Sunset Time at Destination

Cancer

ASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come

Pfizer showcased multiple late-breakers at the American Society of Clinical Oncology’s annual conference but its biggest data are expected later this year.

June 2, 2026

·

6 min read

·

Brianna Abbott

Press Releases

Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy

June 2, 2026

·

8 min read

Press Releases

EssilorLuxottica: Result of the payment of dividends in shares and record of the corresponding capital increase